Hui Zhang – InmunoES

Gut microbiota and sepsis-associated acute kidney injury: a narrative review

2 de June de 2026 by Hui Zhang

BackgroundSepsis-associated acute kidney injury (SA-AKI) carries high morbidity and mortality, yet its pathogenesis remains incompletely understood. Emerging evidence underscores the gut-kidney axis as a critical pathway in SA-AKI development.Objective…

Neutrophil-to-lymphocyte ratio predicts inpatient gout recurrence: a large-scale multicenter retrospective cohort with machine-learning validation

10 de November de 2025 by Hui Zhang

BackgroundThe neutrophil-to-lymphocyte ratio (NLR) is an accessible marker of systemic inflammation. However, its prognostic value for inpatient gout recurrence, particularly in comparison with traditional biomarkers, remains unclear. This study aims t…

Low-dose glucocorticoid improves progression-free survival of children with B cell acute lymphoblastic leukaemia following chimeric antigen receptor T-cell therapy

29 de October de 2025 by Hui Zhang

BackgroundThe prognostic impact of immunosuppressant therapies for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), along with the outcomes and prognosis of children with relapsed/refractory B cell acu…

Heat shock protein 90α may serve as a biomarker for mild cognitive impairment in type 2 diabetes mellitus patients without diabetic nephropathy

12 de May de 2025 by Hui Zhang

AimChronic inflammation associated oxidative stress is a key factor in complications of type 2 diabetes mellitus (T2DM), including mild cognitive impairment (MCI), partly associated with cerebrovascular lesions including both macrovascular and microvas…